EUVIMEDEUVIMED entdecken
Crossref

Extramammary Paget disease: a review

Farishta Khan, Shweta Karakara, Zhenghao Wang iD, Honey Frimpong-Manso, Birgitta van Bodegraven, Jane Sterling, Paul Craig, Andrew Nordin, Zoe C Venables

Clinical and Experimental Dermatology · 28.08.2026

DOI: 10.1093/ced/llag377 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Dermatology, online erschienen am 28.08.2026. Verfasst von Farishta Khan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Norfolk and Norwich University Hospital, Norwich, UK. Die Arbeit nennt 50 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extramammary Paget disease (EMPD) is an uncommon malignancy that affects areas rich in apocrine glands, such as genital and perianal skin. First described by Radcliffe Crocker in 1889, EMPD often remains confined to the epidermis for years, following a quiescent course. Diagnosis is frequently delayed or missed because of its insidious onset and nonspecific symptoms, which can mimic other inflammatory dermatoses. Importantly, EMPD is linked to underlying visceral malignancies, although the risk varies anatomically. Data from England on EMPD incidence and 5-year survival from 2013 to 2020 shows a crude incidence rate of 0.17 per 100 000 person-years. Additionally, the 5-year net survival for EMPD diagnosed in 2013 was 90.9%. The reported net survival for EMPD is comparable with melanoma (89.6%), prostate (85.8%) and breast cancers (85.9%) overall, i.e. for all stages combined. Management of EMPD focuses on identifying and addressing any associated underlying malignancies. Treatment options include surgery or topical treatments, and nonsurgical approaches such as radiotherapy and systemic treatment are used for advanced or metastatic disease. Treatment approaches may not be curative and recurrence rates can be very high, highlighting the importance of close surveillance. This review covers EMPD’s history, classification, epidemiology, aetiology, pathogenesis and diagnosis, and highlights current strategies for malignancy screening and patient management, thus contributing to our understanding of trends and outcomes for this rare disease.

Autor:innen und Institutionen

  • Department of Dermatology, Norfolk and Norwich University Hospital, Norwich, UK.
  • Norwich Medical School, University of East Anglia, Norwich, UK.
  • Mid and South Essex NHS Foundation Trust, Essex, UK.
  • British Association of Dermatologists, London, UK.
  • National Disease Registration Service, Data and Analytics, NHS England, UK.
  • Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

ORCID-Profile: Zhenghao Wang

Zitieren

APA

Khan, F., Karakara, S., Wang, Z., Frimpong-Manso, H., van Bodegraven, B., Sterling, J., Craig, P., Nordin, A., & Venables, Z. C. (2026). Extramammary Paget disease: a review. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llag377

Vancouver

Khan F, Karakara S, Wang Z, Frimpong-Manso H, van Bodegraven B, Sterling J, et al. Extramammary Paget disease: a review. Clinical and Experimental Dermatology. 2026. doi:10.1093/ced/llag377

BibTeX
@article{Khan2026,
  author = {Khan, Farishta and Karakara, Shweta and Wang, Zhenghao and Frimpong-Manso, Honey and van Bodegraven, Birgitta and Sterling, Jane and Craig, Paul and Nordin, Andrew and Venables, Zoe C},
  title = {Extramammary Paget disease: a review},
  journal = {Clinical and Experimental Dermatology},
  year = {2026},
  doi = {10.1093/ced/llag377}
}
Kostenlos starten →